Accolade vs Collective Health

Side-by-side comparison of model-estimated upside.

Accolade

—

est. 2Y upside i

Healthcare

Rank

#4288

Sector

Personalized Healthcare

Data Quality

—

Skipped: Exited (Acquisition by Transcarent)

Last updated: May 5, 2026

Collective Health

-88%

est. 2Y upside i

HealthcareSeries D+

Rank

#3687

Sector

HealthTech

Est. Liquidity

~4Y

Data Quality

Data: Low

Equity upside is deeply negative (-88% expected) due to a stale high valuation, severe preference overhang ($719M vs $1.5B), and strong competitive threats from incumbents.

Last updated: July 21, 2026

Upside Comparison

Expected Upside

Accolade
0%
Collective Health
-88%

Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.